Wróblewska Aneta, Śniechowska Justyna, Kaźmierski Sławomir, Wielgus Ewelina, Bujacz Grzegorz D, Mlostoń Grzegorz, Chworos Arkadiusz, Suwara Justyna, Potrzebowski Marek J
Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland.
Institute of Technical Biochemistry, Lodz University of Technology, Stefanowskiego 4/10, 90-924 Lodz, Poland.
Pharmaceutics. 2020 Apr 15;12(4):359. doi: 10.3390/pharmaceutics12040359.
Two, well defined binary crystals with 1-Hydroxy-4,5-Dimethyl-Imidazole 3-Oxide (HIMO) as coformer and thiobarbituric acid (TBA) as well barbituric acid (BA) as Active Pharmaceutical Ingredients (APIs) were obtained by cocrystallization (from methanol) or mechanochemically by grinding. The progress of cocrystal formation in a ball mill was monitored by means of high-resolution, solid state NMR spectroscopy. The C CP/MAS, N CP/MAS and H Very Fast (VF) MAS NMR procedures were employed to inspect the tautomeric forms of the APIs, structure elucidation of the coformer and the obtained cocrystals. Single crystal X-ray studies allowed us to define the molecular structure and crystal packing for the coformer as well as the TBA/HIMO and BA/HIMO cocrystals. The intermolecular hydrogen bonding, π-π interactions and CH-π contacts responsible for higher order organization of supramolecular structures were determined. Biological studies of HIMO and the obtained cocrystals suggest that these complexes are not cytotoxic and can potentially be considered as therapeutic materials.
通过共结晶(从甲醇中)或通过研磨机械化学法,获得了两种明确的二元晶体,其中以1-羟基-4,5-二甲基咪唑3-氧化物(HIMO)作为共形成物,硫代巴比妥酸(TBA)以及巴比妥酸(BA)作为活性药物成分(API)。通过高分辨率固态核磁共振光谱监测球磨机中共晶体形成的过程。采用碳交叉极化/魔角旋转(C CP/MAS)、氮交叉极化/魔角旋转(N CP/MAS)和氢超快(VF)MAS NMR程序来检查API的互变异构形式、共形成物以及所得共晶体的结构解析。单晶X射线研究使我们能够确定共形成物以及TBA/HIMO和BA/HIMO共晶体的分子结构和晶体堆积。确定了负责超分子结构更高阶组织的分子间氢键、π-π相互作用和CH-π接触。对HIMO和所得共晶体的生物学研究表明,这些复合物没有细胞毒性,有可能被视为治疗材料。